RayzeBio

About:

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

Top Investors: Wellington Management, Deerfield, OrbiMed, Sands Capital Ventures, Cormorant Asset Management

Description:

RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.

Total Funding Amount:

$418M

Headquarters Location:

San Diego, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)rayzebio.com

Founders:

Aron Knickerbocker, Deborah Charych

Number of Employees:

51-100